Bristol-Myers Squibb and Pfizer Inc.'s Bet on This Small Biotech Stock Could Pay Off
Sales of Bristol-Myers Squibb and Pfizer's Eliquis could grow if Portola Pharmaceuticals' andexanet alfa eventually gets FDA approval.
5 Drug Classes Where Prescription Spending Could Grow the Quickest
Prescription drug spending is about to rocket higher and these five drug classes are the reason why.
5 Things Pfizer, Inc.'s Management Wants You to Know
Pfizer's third-quarter earnings report looked rather tame unless you dug into its quarterly conference call. Here are the five key things Pfizer's management wants you to know about where the company is headed next.